21 related articles for article (PubMed ID: 9754918)
1. Selective and potent inhibitory effect of docosahexaenoic acid (DHA) on U46619-induced contraction in rat aorta.
Sato K; Chino D; Kobayashi T; Obara K; Miyauchi S; Tanaka Y
J Smooth Muscle Res; 2013; 49():63-77. PubMed ID: 24304639
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of vasoconstriction by the thromboxane A2 antagonist GR32191B in the human radial artery.
He GW; Yang CQ
Br J Clin Pharmacol; 1999 Aug; 48(2):207-15. PubMed ID: 10417498
[TBL] [Abstract][Full Text] [Related]
3. Novel diacylglycerol kinase inhibitor selectively suppressed an U46619-induced enhancement of mouse portal vein contraction under high glucose conditions.
Nobe K; Miyatake M; Nobe H; Sakai Y; Takashima J; Momose K
Br J Pharmacol; 2004 Sep; 143(1):166-78. PubMed ID: 15289283
[TBL] [Abstract][Full Text] [Related]
4. Alpha-linolenic acid selectively inhibits the contraction of pig coronary arteries mediated through prostanoid TP receptors.
Yoshioka K; Obara K; Ozawa M; Kiguchi M; Nakao Y; Miyaji H; Yamashita T; Saitoh N; Nakagome Y; Tanaka Y
J Pharmacol Sci; 2024 Aug; 155(4):148-151. PubMed ID: 38880549
[TBL] [Abstract][Full Text] [Related]
5. Contractions Induced in Human Pulmonary Arteries by a H
Tunaitytė A; Abramavičius S; Volkevičiūtė A; Venslauskas M; Bubulis A; Bajoriūnas V; Simonsen U; Ostaševičius V; Jūrėnas V; Briedis K; Stankevičius E
Biomolecules; 2024 Feb; 14(3):. PubMed ID: 38540678
[TBL] [Abstract][Full Text] [Related]
6. Prostanoid receptor antagonists: development strategies and therapeutic applications.
Jones RL; Giembycz MA; Woodward DF
Br J Pharmacol; 2009 Sep; 158(1):104-45. PubMed ID: 19624532
[TBL] [Abstract][Full Text] [Related]
7. Potentiation of quantal catecholamine secretion by glibenclamide: evidence for a novel role of sulphonylurea receptors in regulating the Ca(2+) sensitivity of exocytosis.
Taylor SC; Carpenter E; Roberts ML; Peers C
J Neurosci; 1999 Jul; 19(14):5741-9. PubMed ID: 10407015
[TBL] [Abstract][Full Text] [Related]
8. Interspecies differences in thromboxane A2 receptors are distinguished by glibenclamide.
Kemp BK; McPherson GA
Eur J Pharmacol; 1998 Aug; 354(2-3):173-8. PubMed ID: 9754918
[TBL] [Abstract][Full Text] [Related]
9. Glibenclamide inhibits thromboxane A2-induced contraction in human internal mammary artery and saphenous vein.
Stanke F; Cracowski JL; Chavanon O; Magne JL; Blin D; Bessard G; Devillier P
Eur J Pharmacol; 1998 Jan; 341(1):65-71. PubMed ID: 9489857
[TBL] [Abstract][Full Text] [Related]
10. Glibenclamide inhibits thromboxane-mediated vasoconstriction by thromboxane receptor blockade.
Pfister SL; Pratt PE; Kurian J; Campbell WB
Vascul Pharmacol; 2004 Jan; 40(6):285-92. PubMed ID: 15063832
[TBL] [Abstract][Full Text] [Related]
11. GR32191, a highly potent and specific thromboxane A2 receptor blocking drug on platelets and vascular and airways smooth muscle in vitro.
Lumley P; White BP; Humphrey PP
Br J Pharmacol; 1989 Jul; 97(3):783-94. PubMed ID: 2527074
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of glibenclamide on responses to thromboxane A2 mimic, U46619, in the pulmonary and hindquarters vascular beds of the cat.
Kaye AD; Nossaman BD; Santiago JA; DeWitt BJ; Ibrahim IN; Kadowitz PJ
Eur J Pharmacol; 1997 Dec; 340(2-3):187-93. PubMed ID: 9537814
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effect of vapiprost on contractile responses of isolated dog renal arteries to thromboxane A2 analogue, U46619.
Sakanashi M; Matsuzaki T; Noguchi K; Nakasone J; Itomine T; Uza M; Toyama F; Higuchi M
Gen Pharmacol; 1994 Jul; 25(4):617-22. PubMed ID: 7958719
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]